Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Leigh Ann Obanion

Vascular Surgery Fresno, CA Medical Doctor

NPI 1194023259 CMS profile 3995680

1247 E Alluvial Ave Ste 101, Fresno, CA 93720

Open in the dashboard

General payments

$469,132

669 records reported · program years 2019–2025

Research payments

$1,000

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$462,909 paid to institutions, not to them · program years 2021–2025

Through program year 2025, Leigh Ann Obanion of Fresno, CA is reported in the CMS Open Payments database as having received $469,132 across 669 general payments and $1,000 in research payments paid to them. Separately, studies naming them as principal investigator received $462,909 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $199,187 172
2024 General $87,993 132
2023 General $99,427 89
2022 General $41,487 105
2021 General $12,720 73
2020 General $12,429 51
2020 Research $1,000 1
2019 General $15,888 47

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Leigh Ann Obanion
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Leigh Ann Obanion were reported at $199,187. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Leigh Ann Obanion Vascular Surgery median Middle half National median
2019 $15,888 $796 $226–$2,363 $163
2020 $12,429 $348 $118–$1,110 $114
2021 $12,720 $471 $158–$1,421 $132
2022 $41,487 $725 $222–$2,183 $149
2023 $99,427 $836 $257–$2,440 $160
2024 $87,993 $909 $252–$2,619 $164
2025 $199,187 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Shockwave Medical, Inc $302,845 287 payments
  2. Medtronic, Inc. $68,137 118 payments
  3. W. L. Gore & Associates, Inc. $32,526 56 payments
  4. Penumbra, Inc. $30,794 52 payments
  5. Medtronic Vascular, Inc. $25,193 45 payments
  6. Abbott Laboratories $6,074 56 payments
  7. Silk Road Medical, Inc. $2,284 27 payments
  8. Cook Medical LLC $300 4 payments
  9. Inari Medical, Inc. $148 2 payments
  10. Boston Scientific Corporation $147 4 payments
  11. Other $686 18 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $177,220 72 payments
  2. Compensation for serving as faculty or as a speaker for a medical education program $92,100 28 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $75,450 29 payments
  4. Travel and Lodging $68,864 92 payments
  5. Food and Beverage $55,386 446 payments
  6. Education $113 2 payments
Products named General payments · program years 2019–2025
  1. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Cardiology $169,112 116 payments
  2. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Lithoplasty $133,396 164 payments
  3. Indigo System $28,998 36 payments
  4. VENASEAL EndoVenous Therapies $26,532 75 payments
  5. VenaSeal EndoVenous Therapies $24,505 40 payments
  6. Product in Development $23,798 6 payments
  7. VenaSeal EndoVenous Therapies $10,647 25 payments
  8. GORE VIABAHN VBX Balloon Expandable Endo $5,078 7 payments
  9. ClosureFast $4,875 1 payment
  10. GORE EXCLUDER Iliac Branch Endoprosthesis $3,537 4 payments
  11. Other $25,208 264 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic Vascular, Inc. $1,000 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

34

Median for Vascular Surgery: 122

Drug cost

$12,033

Median for Vascular Surgery: $14,135

Branded share of claims

100%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Xarelto Rivaroxaban Brand 12 $11,894
Clopidogrel Clopidogrel Bisulfate Brand 22 $139

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 64 billing codes

Paid by Medicare

$133,521

Medicare's payments for the services billed

Medicare patients

185

Average age 75

Services billed

662

105 women, 80 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 61%
Arthritis 56%
Ischemic heart disease 54%
Chronic kidney disease 41%
Heart failure 32%
Depression 24%
Atrial fibrillation 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

670 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record